Mitchell L. Drumm

发表

Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid‐derived cells slows resolution of inflammation and infection

M. Drumm, C. Hodges, C. Cotton, 2012, Journal of leukocyte biology.

Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease

M. Drumm, B. Aronow, C. Langefeld, 2009, Nature.

Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2

Fred A. Wright, Fei Zou, Clayton W. Commander, 2011, Nature Genetics.

Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter.

M. Drumm, T. Flotte, W. Guggino, 1993, The Journal of biological chemistry.

Cystic fibrosis-related diabetes is caused by islet loss and Cystic fibrosis-related diabetes is caused by islet loss and inflammation inflammation

A. Spigelman, C. Dai, A. Powers, 2022 .

Glycogen storage diseases

T. Derks, P. Kishnani, William B. Hannah, 2023, Nature Reviews Disease Primers.

Stimulation of cystic fibrosis transmembrane conductance regulator-dependent short-circuit currents across DeltaF508 murine intestines.

M. Drumm, W. Steagall, Mitchell L. Drumm, 1999, Gastroenterology.

Cystic Fibrosis Mice Develop Spontaneous Chronic Bordetella Airway Infections

C. Hodges, F. Jacono, R. Darrah, 2017, Journal of infectious pulmonary diseases.

Human epithelial cystic fibrosis transmembrane conductance regulator without exon 5 maintains partial chloride channel function in intracellular membranes.

M. Drumm, P. Davis, J. Zhao, 1996, Biophysical journal.

In vivo editing of lung stem cells for durable gene correction in mice

C. Hodges, Pratima Basak, S. Abid, 2024, Science.

3849+10 kb C→T mutation and disease severity in cystic fibrosis

M. Drumm, R. Stern, C. Doershuk, 1995, The Lancet.